Effects of Omegaven®, EPA, DHA and Oxaliplatin on Oesophageal Adenocarcinoma Cell Lines Growth, Cytokine and Cell Signal Biomarkers Expression

Overview

Journal Lipids Health Dis

Publisher Biomed Central

Specialties Biochemistry
Endocrinology

Date 2018 Jan 31

PMID 29378575

Citations 4

Authors

Amar M Eltweri

Lynne M Howells

Anne L Thomas

Ashley R Dennison

David J Bowrey

Affiliations

Soon will be listed here.

Abstract

Background: There is limited evidence assessing the effects of omega-3 polyunsaturated fatty acids (PUFAs) on oesophageal adenocarcinoma, both in vitro and in vivo. We evaluated the effects of the omega-3 PUFA and oxaliplatin on OE33 and OE19 cells.

Method: The two oesophageal cells were treated with Omegaven® (fish oil emulsion), EPA, DHA and oxaliplatin and incubated for up to 144 h.

Results: The following inhibitory effects were observed on OE33 cells: EPA reduced cell growth by 39% (p = 0.001), DHA by 59% (p < 0.000) and Oxaliplatin by 77% (p < 0.000). For OE19 cells, the EPA reduced growth by 1% (p = 0.992), DHA by 26% (p = 0.019) and oxaliplatin by 76% (p < 0.000). For both cells, Omegaven® resulted in reduced cell growth at intermediate concentrations (20-40 μM) and increased cell growth at low (10 μM) and high (50 μM) concentrations. DHA, Omegaven® and oxaliplatin were associated with significant downregulation of VEGF and p53 protein, and upregulation of p21 protein. DHA, Omegaven® and Oxaliplatin also led to significant downregulation of the total ERK1/2 and Akt proteins.

Conclusion: DHA, Omegaven® and oxaliplatin were associated with downregulation of p53 and VEGF in both cells. Of the PUFAs studied, DHA alone or in combination (Omegaven®) had greater in vitro anti-cancer effects than EPA alone.

Citing Articles

EPA and DHA promote cell proliferation and enhance activity of the Akt-TOR-S6K anabolic signaling pathway in primary muscle cells of turbot (Scophthalmus maximus L.).

Gao Y, Liu C, Wang X, Zhou H, Mai K, He G Fish Physiol Biochem. 2024; 50(4):1483-1494.

PMID: 38814520 DOI: 10.1007/s10695-024-01351-4.

Pharmaceutical nanoformulation strategies to spatiotemporally manipulate oxidative stress for improving cancer therapies - exemplified by polyunsaturated fatty acids and other ROS-modulating agents.

Zhang R, Liu F, Lip H, Liu J, Zhang Q, Wu X Drug Deliv Transl Res. 2022; 12(10):2303-2334.

PMID: 35064476 DOI: 10.1007/s13346-021-01104-3.

MYCN and PRC1 cooperatively repress docosahexaenoic acid synthesis in neuroblastoma via ELOVL2.

Ding Y, Yang J, Ma Y, Yao T, Chen X, Ge S J Exp Clin Cancer Res. 2019; 38(1):498.

PMID: 31856871 PMC: 6923955. DOI: 10.1186/s13046-019-1492-5.

Omega-3 Polyunsaturated Fatty Acids and Their Bioactive Metabolites in Gastrointestinal Malignancies Related to Unresolved Inflammation. A Review.

Irun P, Lanas A, Piazuelo E Front Pharmacol. 2019; 10:852.

PMID: 31427966 PMC: 6687876. DOI: 10.3389/fphar.2019.00852.

References

Kato T, Kolenic N, Pardini R . Docosahexaenoic acid (DHA), a primary tumor suppressive omega-3 fatty acid, inhibits growth of colorectal cancer independent of p53 mutational status. Nutr Cancer. 2007; 58(2):178-87. DOI: 10.1080/01635580701328362. View

Calder P . Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. Biochim Biophys Acta. 2014; 1851(4):469-84. DOI: 10.1016/j.bbalip.2014.08.010. View

Calder P . Mechanisms of action of (n-3) fatty acids. J Nutr. 2012; 142(3):592S-599S. DOI: 10.3945/jn.111.155259. View

Chi T, Chen G, Lai P . Eicosapentaenoic acid induces Fas-mediated apoptosis through a p53-dependent pathway in hepatoma cells. Cancer J. 2004; 10(3):190-200. DOI: 10.1097/00130404-200405000-00009. View

Cai H, Scott E, Kholghi A, Andreadi C, Rufini A, Karmokar A . Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice. Sci Transl Med. 2015; 7(298):298ra117. PMC: 4827609. DOI: 10.1126/scitranslmed.aaa7619. View

Eltweri A, Thomas A, Metcalfe M, Calder P, Dennison A, Bowrey D . Potential applications of fish oils rich in omega-3 polyunsaturated fatty acids in the management of gastrointestinal cancer. Clin Nutr. 2016; 36(1):65-78. DOI: 10.1016/j.clnu.2016.01.007. View

Calder P . Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?. Br J Clin Pharmacol. 2012; 75(3):645-62. PMC: 3575932. DOI: 10.1111/j.1365-2125.2012.04374.x. View

Lochhead P, El-Omar E . Helicobacter pylori infection and gastric cancer. Best Pract Res Clin Gastroenterol. 2007; 21(2):281-97. DOI: 10.1016/j.bpg.2007.02.002. View

Granci V, Cai F, Lecumberri E, Clerc A, Dupertuis Y, Pichard C . Colon cancer cell chemosensitisation by fish oil emulsion involves apoptotic mitochondria pathway. Br J Nutr. 2012; 109(7):1188-95. DOI: 10.1017/S000711451200308X. View

10.

Calviello G, Di Nicuolo F, Gragnoli S, Piccioni E, Serini S, Maggiano N . n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway. Carcinogenesis. 2004; 25(12):2303-10. DOI: 10.1093/carcin/bgh265. View

11.

Aggarwal B, Gehlot P . Inflammation and cancer: how friendly is the relationship for cancer patients?. Curr Opin Pharmacol. 2009; 9(4):351-69. PMC: 2730981. DOI: 10.1016/j.coph.2009.06.020. View

12.

Zhuo Z, Zhang L, Mu Q, Lou Y, Gong Z, Shi Y . The effect of combination treatment with docosahexaenoic acid and 5-fluorouracil on the mRNA expression of apoptosis-related genes, including the novel gene BCL2L12, in gastric cancer cells. In Vitro Cell Dev Biol Anim. 2008; 45(1-2):69-74. DOI: 10.1007/s11626-008-9154-5. View

13.

Shih C, Ozawa S, Ando N, Ueda M, Kitajima M . Vascular endothelial growth factor expression predicts outcome and lymph node metastasis in squamous cell carcinoma of the esophagus. Clin Cancer Res. 2000; 6(3):1161-8. View

14.

De Carlo F, Witte T, Hardman W, Claudio P . Omega-3 eicosapentaenoic acid decreases CD133 colon cancer stem-like cell marker expression while increasing sensitivity to chemotherapy. PLoS One. 2013; 8(7):e69760. PMC: 3713061. DOI: 10.1371/journal.pone.0069760. View

15.

Hardy S, St-Onge G, Joly E, Langelier Y, Prentki M . Oleate promotes the proliferation of breast cancer cells via the G protein-coupled receptor GPR40. J Biol Chem. 2005; 280(14):13285-91. DOI: 10.1074/jbc.M410922200. View

16.

Lavigne J, Takahashi Y, Chandramouli G, Liu H, Perkins S, Hursting S . Concentration-dependent effects of genistein on global gene expression in MCF-7 breast cancer cells: an oligo microarray study. Breast Cancer Res Treat. 2007; 110(1):85-98. DOI: 10.1007/s10549-007-9705-6. View

17.

Slagsvold J, Pettersen C, Storvold G, Follestad T, Krokan H, Schonberg S . DHA alters expression of target proteins of cancer therapy in chemotherapy resistant SW620 colon cancer cells. Nutr Cancer. 2010; 62(5):611-21. DOI: 10.1080/01635580903532366. View

18.

Lee S, Lim J, Kim H . Activator protein-1 mediates docosahexaenoic acid-induced apoptosis of human gastric cancer cells. Ann N Y Acad Sci. 2009; 1171:163-9. DOI: 10.1111/j.1749-6632.2009.04716.x. View

19.

Hardy S, Langelier Y, Prentki M . Oleate activates phosphatidylinositol 3-kinase and promotes proliferation and reduces apoptosis of MDA-MB-231 breast cancer cells, whereas palmitate has opposite effects. Cancer Res. 2000; 60(22):6353-8. View

20.

Hering J, Garrean S, Dekoj T, Razzak A, Saied A, Trevino J . Inhibition of proliferation by omega-3 fatty acids in chemoresistant pancreatic cancer cells. Ann Surg Oncol. 2007; 14(12):3620-8. DOI: 10.1245/s10434-007-9556-8. View